KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic diagnosis, today announced ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of fighting cancer.

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...